Read + Share
Amedeo Smart
Independent Medical Education
Jiang ZP, Shan HM, Zhu HY, Cheng Y, et al. The Prognostic Value of Baseline 18F-FDG PET/CT in Stage IV Non-Small Cell Lung Cancer Patients Receiving Osimertinib Treatment. Clin Nucl Med 2025 Jul 14. doi: 10.1097/RLU.0000000000006039.PMID: 40658988
Email
LinkedIn
Privacy Policy